ArticleWorld journal of gastroenterology2025
Distal small bowel resection with preservation of the terminal ileum suppresses hepatic gluconeogenesis
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Mechanisms of Intestinal Adaptation in Short Bowel Syndrome: A Comprehensive Review.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDistal small bowel resection with preservation of the terminal ileum (DBRPI) significantly improves glucose metabolism in rats.
aimTo explore the underlying mechanisms of DBRPI in improving glucose metabolism.
methodsFollowing 8 weeks of a high-fat diet, the rats were randomly divided into the DBRPI group and the sham operation group. After surgery, body weight and glucose tolerance were monitored. At 6 weeks post-surgery, the composition of intestinal microbiota, bile acid levels, and the expression of farnesoid X receptor (FXR), Takeda G protein-coupled receptor 5, and glucagon-like peptide-1 (GLP-1) in the ileum were examined. Additionally, the gene expression of key enzymes involved in gluconeogenesis in the liver was evaluated.
resultsDBRPI reduced body weight and improved glucose tolerance. At 6 weeks post-surgery, the abundance of
conclusionDBRPI inhibits hepatic gluconeogenesis and improves glucose metabolism. The mechanism may be related to activation of the 7-KLCA-FXR signaling pathway mediated by the
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.